Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Georgetown University
Memorial Sloan Kettering Cancer Center
Assistance Publique - Hôpitaux de Paris
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
Allogene Therapeutics
BeOne Medicines
City of Hope Medical Center
Seattle Children's Hospital
M.D. Anderson Cancer Center
GeoVax, Inc.
Center for International Blood and Marrow Transplant Research
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Seattle Children's Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Baylor College of Medicine
Children's Oncology Group
University College, London
Stanford University
University Hospital, Angers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Colorado, Denver
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Seattle Children's Hospital
Seattle Children's Hospital
Seattle Children's Hospital
Montreal Heart Institute
Rigshospitalet, Denmark
City of Hope Medical Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
University of Virginia
Tempus AI
Genmab
Ono Pharmaceutical Co. Ltd
UNC Lineberger Comprehensive Cancer Center
Acerta Pharma BV